Effects of sodium‐glucose cotransporter type 2 inhibitors on cardiovascular, renal, and safety outcomes in patients with cardiovascular disease: a meta‐analysis of randomized controlled trials

被引：0
|
作者：
Caiyun Zheng
Meimei Lin
Yan Chen
Haiting Xu
Lingqun Yan
Hengfen Dai
机构：
[1] Affiliated Fuqing City Hospital of Fujian Medical University,
[2] Fujian Medical University,undefined
[3] Affiliated Fuzhou First Hospital of Fujian Medical University,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Sodium glucose cotransporter type 2 inhibitors; Cardiovascular disease; Mortality; Meta‐analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials
    Mengnan Li
    Jian Zhang
    Guimei Yang
    Jiaxin Zhang
    Minmin Han
    Yi Zhang
    Yunfeng Liu
    European Journal of Clinical Pharmacology, 2023, 79 : 859 - 871
  • [22] Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials
    Li, Mengnan
    Zhang, Jian
    Yang, Guimei
    Zhang, Jiaxin
    Han, Minmin
    Zhang, Yi
    Liu, Yunfeng
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (06) : 859 - 871
  • [23] Cardiovascular effects of sodium glucose cotransporter 2 inhibitors
    Cavaiola, Tricia Santos
    Pettus, Jeremy
    DIABETES METABOLIC SYNDROME AND OBESITY, 2018, 11 : 133 - 148
  • [24] The effects of Sodium-glucose cotransporter 2 inhibitors on adipose tissue in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
    Liu, Xindong
    Chen, Ying
    Liu, Tao
    Cai, Ling
    Yang, Xiaofeng
    Mou, Chuan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [25] Effects of SGLT2 inhibitors on cardiovascular, renal, and major safety outcomes in heart failure: A meta-analysis of randomized controlled trials
    Li, Xuexun
    Zhang, Qian
    Zhu, Lingming
    Wang, Guangqiang
    Ge, Peipei
    Hu, Aizhen
    Sun, Xuerong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 332 : 119 - 126
  • [26] Sodium-glucose cotransporter 2 inhibitors and cardiovascular outcomes
    Steinberg, Helmut O.
    POSTGRADUATE MEDICINE, 2016, 128 (04) : 398 - 408
  • [27] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes - A systematic review
    Radholm, Karin
    Wu, Jason H. Y.
    Wong, Muh Geot
    Foote, Celine
    Fulcher, Gregory
    Mahaffey, Kenneth W.
    Perkovic, Vlado
    Neal, Bruce
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 140 : 118 - 128
  • [28] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [29] Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
    Salah, Husam M.
    Al'Aref, Subhi J.
    Khan, Muhammad Shahzeb
    Al-Hawwas, Malek
    Vallurupalli, Srikanth
    Mehta, Jawahar L.
    Mounsey, J. Paul
    Greene, Stephen J.
    McGuire, Darren K.
    Lopes, Renato D.
    Fudim, Marat
    AMERICAN HEART JOURNAL, 2021, 233 : 86 - 91
  • [30] Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis
    Deshpande, Radhika
    Patel, Raj
    Regmi, Manjari R.
    Salih, Mohsin
    Kropp, Robert
    Al-Bast, Basma
    Sheikh, Muhammad A.
    Sagalov, Andrew
    Kulkarni, Abhishek
    Siddique, Momin
    Hegde, Shruti
    Bhattarai, Mukul
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2023, 12 (02):
12345